ArticleInternational journal of hematology2023
Daratumumab plus lenalidomide and dexamethasone for relapsed POEMS syndrome with bone plasmacytoma harboring 17p deletion.
Takashi Oyama et al.PubMed ↗Publisher ↗
No numbers read from the abstract.
1 paper cites it
this papercites it